Global Head Lice Infestation Treatment Market Size, Share, Trends and Forecast 2022-2030

Description

Head lice are small, wingless, blood-sucking insects that attack the hair. They feed on the blood of your scalp, which causes irritation or sometimes large pimples on the head. The male lice are much larger compared to the female lice. Head lice are transmissible if you get infected with head lice. Head lice are characterized by symptoms such as severe itching, tingling sensation when the hair moves, and sores on the scalp, neck, and shoulders. Head lice infestation is caused by poor personal hygiene. Head lice can be treated with over-the-counter drugs and prescribed drugs. There are many treatment options available to get rid of head lice, but most treatments need to be used twice or more. The second treatment takes place after a week to kill any newly hatched nits.
Industry Insights

Due to the COVID-19 pandemic, the global Head Lice Infestation Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Head Lice Infestation Treatment market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Head Lice Infestation Treatment landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

In North America and Europe, Head Lice Infestation Treatment key players include Stada Arzneimittel, Reckitt Benckier, Oystershell Consumer Health, Prestige Brands, Perrigo, etc. Top five manufacturers hold a share about 60%.

Europe is the larger market, with a share over 55%, followed by North America , which has a share over 40%.

In terms of product, OTC is the largest segment, with a share over 95%. And in terms of application, the largest application is children, followed by adults.

This report focuses on Head Lice Infestation Treatment volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Head Lice Infestation Treatment market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan and China, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Head Lice Infestation Treatment market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

OTC

Prescription

Segment by End User

Children

Adults

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Arbor Pharmaceuticals

Stada Arzneimittel

Prestige Brands

Oystershell Consumer Health

Reckitt Benckier

Perrigo

ParaPRO

TecLabs

Alliance Pharma Inc.

Nuvo Pharmaceuticals

Medexus Pharmaceuticals

Logic Product Group

TABLE OF CONTENT

1 Head Lice Infestation Treatment Market Overview
1.1 Product Overview and Scope of Head Lice Infestation Treatment

1.2 Head Lice Infestation Treatment Segment by Type

1.2.1 Global Head Lice Infestation Treatment Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 OTC

1.2.3 Prescription

1.3 Head Lice Infestation Treatment Segment by End User

1.3.1 Global Head Lice Infestation Treatment Sales Comparison by End User: (2022-2028)

1.3.2 Children

1.3.3 Adults

1.4 Global Head Lice Infestation Treatment Market Size Estimates and Forecasts

1.4.1 Global Head Lice Infestation Treatment Revenue 2017-2028

1.4.2 Global Head Lice Infestation Treatment Sales 2017-2028

1.4.3 Head Lice Infestation Treatment Market Size by Region: 2017 Versus 2021 Versus 2028

2 Head Lice Infestation Treatment Market Competition by Manufacturers

2.1 Global Head Lice Infestation Treatment Sales Market Share by Manufacturers (2017-2022)

2.2 Global Head Lice Infestation Treatment Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Head Lice Infestation Treatment Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Head Lice Infestation Treatment Manufacturing Sites, Area Served, Product Type

2.5 Head Lice Infestation Treatment Market Competitive Situation and Trends

2.5.1 Head Lice Infestation Treatment Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Head Lice Infestation Treatment Players Market Share by Revenue

2.5.3 Global Head Lice Infestation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Head Lice Infestation Treatment Retrospective Market Scenario by Region

3.1 Global Head Lice Infestation Treatment Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Head Lice Infestation Treatment Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Head Lice Infestation Treatment Market Facts & Figures by Country

3.3.1 North America Head Lice Infestation Treatment Sales by Country

3.3.2 North America Head Lice Infestation Treatment Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe Head Lice Infestation Treatment Market Facts & Figures by Country

3.4.1 Europe Head Lice Infestation Treatment Sales by Country

3.4.2 Europe Head Lice Infestation Treatment Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Head Lice Infestation Treatment Market Facts & Figures by Region

3.5.1 Asia Pacific Head Lice Infestation Treatment Sales by Region

3.5.2 Asia Pacific Head Lice Infestation Treatment Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Head Lice Infestation Treatment Market Facts & Figures by Country

3.6.1 Latin America Head Lice Infestation Treatment Sales by Country

3.6.2 Latin America Head Lice Infestation Treatment Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Head Lice Infestation Treatment Market Facts & Figures by Country

3.7.1 Middle East and Africa Head Lice Infestation Treatment Sales by Country

3.7.2 Middle East and Africa Head Lice Infestation Treatment Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Head Lice Infestation Treatment Historic Market Analysis by Type

4.1 Global Head Lice Infestation Treatment Sales Market Share by Type (2017-2022)

4.2 Global Head Lice Infestation Treatment Revenue Market Share by Type (2017-2022)

4.3 Global Head Lice Infestation Treatment Price by Type (2017-2022)

5 Global Head Lice Infestation Treatment Historic Market Analysis by End User

5.1 Global Head Lice Infestation Treatment Sales Market Share by End User (2017-2022)

5.2 Global Head Lice Infestation Treatment Revenue Market Share by End User (2017-2022)

5.3 Global Head Lice Infestation Treatment Price by End User (2017-2022)

6 Key Companies Profiled

6.1 Arbor Pharmaceuticals

6.1.1 Arbor Pharmaceuticals Corporation Information

6.1.2 Arbor Pharmaceuticals Description and Business Overview

6.1.3 Arbor Pharmaceuticals Head Lice Infestation Treatment Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Arbor Pharmaceuticals Head Lice Infestation Treatment Product Portfolio

6.1.5 Arbor Pharmaceuticals Recent Developments/Updates

6.2 Stada Arzneimittel

6.2.1 Stada Arzneimittel Corporation Information

6.2.2 Stada Arzneimittel Description and Business Overview

6.2.3 Stada Arzneimittel Head Lice Infestation Treatment Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Stada Arzneimittel Head Lice Infestation Treatment Product Portfolio

6.2.5 Stada Arzneimittel Recent Developments/Updates

6.3 Prestige Brands

6.3.1 Prestige Brands Corporation Information

6.3.2 Prestige Brands Description and Business Overview

6.3.3 Prestige Brands Head Lice Infestation Treatment Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Prestige Brands Head Lice Infestation Treatment Product Portfolio

6.3.5 Prestige Brands Recent Developments/Updates

6.4 Oystershell Consumer Health

6.4.1 Oystershell Consumer Health Corporation Information

6.4.2 Oystershell Consumer Health Description and Business Overview

6.4.3 Oystershell Consumer Health Head Lice Infestation Treatment Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Oystershell Consumer Health Head Lice Infestation Treatment Product Portfolio

6.4.5 Oystershell Consumer Health Recent Developments/Updates

6.5 Reckitt Benckier

6.5.1 Reckitt Benckier Corporation Information

6.5.2 Reckitt Benckier Description and Business Overview

6.5.3 Reckitt Benckier Head Lice Infestation Treatment Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Reckitt Benckier Head Lice Infestation Treatment Product Portfolio

6.5.5 Reckitt Benckier Recent Developments/Updates

6.6 Perrigo

6.6.1 Perrigo Corporation Information

6.6.2 Perrigo Description and Business Overview

6.6.3 Perrigo Head Lice Infestation Treatment Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Perrigo Head Lice Infestation Treatment Product Portfolio

6.6.5 Perrigo Recent Developments/Updates

6.7 ParaPRO

6.6.1 ParaPRO Corporation Information

6.6.2 ParaPRO Description and Business Overview

6.6.3 ParaPRO Head Lice Infestation Treatment Sales, Revenue and Gross Margin (2017-2022)

6.4.4 ParaPRO Head Lice Infestation Treatment Product Portfolio

6.7.5 ParaPRO Recent Developments/Updates

6.8 TecLabs

6.8.1 TecLabs Corporation Information

6.8.2 TecLabs Description and Business Overview

6.8.3 TecLabs Head Lice Infestation Treatment Sales, Revenue and Gross Margin (2017-2022)

6.8.4 TecLabs Head Lice Infestation Treatment Product Portfolio

6.8.5 TecLabs Recent Developments/Updates

6.9 Alliance Pharma Inc.

6.9.1 Alliance Pharma Inc. Corporation Information

6.9.2 Alliance Pharma Inc. Description and Business Overview

6.9.3 Alliance Pharma Inc. Head Lice Infestation Treatment Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Alliance Pharma Inc. Head Lice Infestation Treatment Product Portfolio

6.9.5 Alliance Pharma Inc. Recent Developments/Updates

6.10 Nuvo Pharmaceuticals

6.10.1 Nuvo Pharmaceuticals Corporation Information

6.10.2 Nuvo Pharmaceuticals Description and Business Overview

6.10.3 Nuvo Pharmaceuticals Head Lice Infestation Treatment Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Nuvo Pharmaceuticals Head Lice Infestation Treatment Product Portfolio

6.10.5 Nuvo Pharmaceuticals Recent Developments/Updates

6.11 Medexus Pharmaceuticals

6.11.1 Medexus Pharmaceuticals Corporation Information

6.11.2 Medexus Pharmaceuticals Head Lice Infestation Treatment Description and Business Overview

6.11.3 Medexus Pharmaceuticals Head Lice Infestation Treatment Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Medexus Pharmaceuticals Head Lice Infestation Treatment Product Portfolio

6.11.5 Medexus Pharmaceuticals Recent Developments/Updates

6.12 Logic Product Group

6.12.1 Logic Product Group Corporation Information

6.12.2 Logic Product Group Head Lice Infestation Treatment Description and Business Overview

6.12.3 Logic Product Group Head Lice Infestation Treatment Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Logic Product Group Head Lice Infestation Treatment Product Portfolio

6.12.5 Logic Product Group Recent Developments/Updates

7 Head Lice Infestation Treatment Manufacturing Cost Analysis

7.1 Head Lice Infestation Treatment Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Head Lice Infestation Treatment

7.4 Head Lice Infestation Treatment Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Head Lice Infestation Treatment Distributors List

8.3 Head Lice Infestation Treatment Customers

9 Head Lice Infestation Treatment Market Dynamics

9.1 Head Lice Infestation Treatment Industry Trends

9.2 Head Lice Infestation Treatment Market Drivers

9.3 Head Lice Infestation Treatment Market Challenges

9.4 Head Lice Infestation Treatment Market Restraints

10 Global Market Forecast

10.1 Head Lice Infestation Treatment Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Head Lice Infestation Treatment by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Head Lice Infestation Treatment by Type (2023-2028)

10.2 Head Lice Infestation Treatment Market Estimates and Projections by End User

10.2.1 Global Forecasted Sales of Head Lice Infestation Treatment by End User (2023-2028)

10.2.2 Global Forecasted Revenue of Head Lice Infestation Treatment by End User (2023-2028)

10.3 Head Lice Infestation Treatment Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Head Lice Infestation Treatment by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Head Lice Infestation Treatment by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample